Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03422653 | A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1) | ||
| NCT04777981 | (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC | ||
| NCT06507839 | Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268 | ||
| NCT00100672 | Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer | ||
| NCT01431339 | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | ||
| NCT04797715 | Assessing Clinical Outcomes in Alzheimer's Disease Agitation | ||
| NCT04243486 | A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis | ||
| NCT05355753 | A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors | ||
| NCT00607373 | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia | ||
| NCT03340883 | Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) | ||
| NCT05025605 | Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder | ||
| NCT04661137 | A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma | ||
| NCT01016873 | INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD | ||
| NCT04399395 | Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery | ||
| NCT06568367 | Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) | ||
| NCT05227287 | ADH1 and ADH2 Disease Monitoring Study (DMS) | ||
| NCT04965753 | FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors | ||
| NCT02909972 | Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT04414163 | A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type | ||
| NCT03973840 | Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes | ||
| NCT01986920 | Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis | ||
| NCT02310581 | Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | ||
| NCT04607772 | Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) | ||
| NCT03194139 | A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers | ||
| NCT02341807 | Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations | ||
| NCT01819272 | Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks | ||
| NCT06762457 | A First-in-Human Single and Multiple Ascending Dose Study of MT-501 | ||
| NCT03988530 | Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects | ||
| NCT06465199 | Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas | ||
| NCT03836001 | A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa | ||
| NCT02134301 | Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections | ||
| NCT04886765 | A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma | ||
| NCT05110664 | APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE | ||
| NCT04683627 | A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee | ||
| NCT03311373 | A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 | ||
| NCT04606602 | Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) | ||
| NCT00217139 | A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection | ||
| NCT04534439 | Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy | ||
| NCT06150924 | Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria | ||
| NCT03455270 | G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer | ||
| NCT02530905 | Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients | ||
| NCT02802631 | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults | ||
| NCT05649917 | SPR PNS for Chronic Shoulder Pain | ||
| NCT04789174 | Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study | ||
| NCT02500459 | Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection | ||
| NCT00911586 | Pharmacokinetic Study to Determine Time to Steady-state | ||
| NCT06932146 | A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones | ||
| NCT02831686 | A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma | ||
| NCT05429073 | A Study of RGLS8429 in Healthy Volunteers |
